NCT00429260View on ClinicalTrials.gov

A Study Evaluating the Safety and Tolerability of Abrupt Discontinuation of Saredutant in Patients With Depression

PHASE3CompletedINTERVENTIONAL
Enrollment

125

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

June 30, 2007

Study Completion Date

June 30, 2007

Conditions
Depressive Disorder
Interventions
DRUG

Saredutant

Trial Locations (1)

19355

Administrative Office, Malvern

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT00429260 - A Study Evaluating the Safety and Tolerability of Abrupt Discontinuation of Saredutant in Patients With Depression | Biotech Hunter | Biotech Hunter